VolitionRX (AMEX: VNRX)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-10 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.020 | -0.140 | -0.1600 | ||||
REV | 10.030M | 114.211K | -9.916M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of VolitionRX (AMEX: VNRX) through any online brokerage.
There are no as such competitors for VolitionRX.
The latest price target for VolitionRX (AMEX: VNRX) was reported by Aegis Capital on Tuesday, November 16, 2021. The analyst firm set a price target for 9.00 expecting VNRX to rise to within 12 months (a possible 336.87% upside). 1 analyst firms have reported ratings in the last year.
The stock price for VolitionRX (AMEX: VNRX) is $2.0601 last updated Today at June 29, 2022, 7:12 PM UTC.
There are no upcoming dividends for VolitionRX.
VolitionRX’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for VolitionRX.
VolitionRX is in the Healthcare sector and Diagnostics & Research industry. They are listed on the AMEX.